comparemela.com
Home
Live Updates
Sipavibart Promising for COVID-19 Prevention in Immunocompromised Patients : comparemela.com
Sipavibart Promising for COVID-19 Prevention in Immunocompromised Patients
Sipavibart is an investigational long-acting monoclonal antibody.
Related Keywords
Ghady Haidar ,
Astrazeneca ,
University Of Pittsburgh Medical Center ,
Pittsburgh Medical Center ,
comparemela.com © 2020. All Rights Reserved.